WMSA
GYRE icon

Weiss Multi-Strategy Advisers’s Gyre Therapeutics GYRE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-59
Closed -$130K – 435
2015
Q2 		$130K Hold
59
– – 0.01% 425
2015
Q1 		$138K Sell
59
-11
-16% -$22.7K 0.01% 410
2014
Q4 		$145K Hold
70
– – 0.01% 384
2014
Q3 		$139K Buy
70
+7
+11% +$17.3K ﹤0.01% 502
2014
Q2 		$226K Buy
+63
New +$206K ﹤0.01% 682

Other funds holding GYRE

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GYRE Position: Q3 2015 in Review

Weiss Multi-Strategy Advisers sold out of Gyre Therapeutics (GYRE) in Q3 2015, closing a stake of 59 shares — an estimated $130K sold.

Weiss Multi-Strategy Advisers first reported a position in GYRE in Q2 2014 and held it in 5 quarters. The position peaked at $226K in Q2 2014. 39 funds tracked by Wall St. Rank hold GYRE as of Q3 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Gyre Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 59 Gyre Therapeutics shares in Q3 2015, an estimated $130K.
  • Weiss Multi-Strategy Advisers first reported a position in Gyre Therapeutics in Q2 2014 and held it in 5 quarters.
  • Weiss Multi-Strategy Advisers's Gyre Therapeutics position peaked at $226K in Q2 2014.
  • 39 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2015, filed 16 Nov 2015.